Refine by
Therapeutic Development Articles & Analysis
542 news found
By leveraging a suite of biomimetic and AI-powered technologies, BBBporter™ enables the efficient transport of therapeutic candidates into the brain, opening new avenues for preclinical drug development in areas such as Alzheimer's disease, Parkinson's disease, stroke, and epilepsy. ...
Due to their unique specificity and high activity, enzymes demonstrate significant potential in therapeutic drug development. However, their broader application is hindered by several limitations, the most significant of which are poor stability, potential immunogenicity and systemic toxicity risks. ...
Creative BioMart, a biotechnology company focused on protein-related research solutions, has recently upgraded its epitope mapping service to better support researchers in therapeutic antibody development, vaccine design, and immunogenicity studies. ...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the expansion and enhancement of its comprehensive Drug Discovery Services to help scientists advance antiviral therapeutic development, including target selection and validation, hit selection and optimization, and preclinical ...
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of ...
Stem cell exosomes, in particular, have garnered significant attention due to their regenerative, anti-inflammatory, and immunomodulatory properties, making them invaluable in therapeutic applications and medical research. Creative Biostructure's expanded catalog now features exosomes isolated from a variety of stem cell sources, including: l Mesenchymal Stem Cells (MSCs): ...
(Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to announce that its mPEG-pALD (20K) has successfully completed its Drug Master File (DMF) filing with the U.S. ...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its Zika Virus Animal Model services for scientists to understand the complex mechanisms of Zika virus infection and develop effective countermeasures. These models are valuable tools in the research and development of vaccines and ...
Protheragen is proud to release the launch of its comprehensive vaccine development solutions tailored to advance research and development in the field of infectious diseases. ...
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
Alfa Chemistry makes this possible by providing pure and highly diverse nucleosides with modified versions used in the development of oligonucleotide therapeutics. These nucleosides are not just helpful in generating genes but also for the production of anticancer and antiviral drugs that could make medicines that work and are well tolerated in all manner of ...
To meet the growing needs of the research community, Profacgen’s enhanced AMPs services now offer a more comprehensive suite of solutions aimed at accelerating the discovery and development of these promising therapeutic agents. The company’s updated services provide robust support for the entire peptide development process—from ...
Ace Therapeutics is excited to announce the launch of its groundbreaking glaucoma gene therapy development services. ...
Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. ...
The AI-powered system evaluates important characteristics, such as binding affinity and pharmacokinetics, to refine compounds and enhance their therapeutic potential. This iterative process facilitates the creation of drug candidates that not only show promise in early trials but are also more likely to advance through the rigorous drug development pipeline. ...
It primarily serves researchers with its state-of-the-art facilities and experienced team, which specializes in the synthesis and development of a broad range of drug conjugates. By leveraging their vast expertise in active pharmaceutical ingredient (API) binding technologies, CD Formulation facilitates the production of new chemical entities (NCEs) that are crucial for the ...
They are essential for the efficient transportation of mRNA to target cells, ensuring that therapeutic mRNA is delivered to the cytoplasm, where it can effectively produce the target protein. ...
Introduction We recently sat down with one of our valued customers, Dr Alexis Rossignol (Clean Cells), to discuss his experience with VIPS PRO, our cutting-edge technology designed to streamline and enhance the early stages of cell line development. This interview provides insight into Clean Cells’ quest to automate and increase single-cell seeding while having undisputable proof ...
Ace Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. ...
This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational modification, significantly impacts protein folding, stability, and activity. ...